Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
07 March 2019Website:
http://www.shockwavemedical.comNext earnings report:
05 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Thu, 30 May 2024 20:00:01 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
SWAV Latest News
NEW YORK , May 29, 2024 /PRNewswire/ -- Sarepta Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.
Shockwave Medical (SWAV) reported quarterly earnings of $1.44 per share, exceeding the Zacks Consensus Estimate of $1.04 per share. This is an increase from earnings of $1.03 per share in the same quarter last year.
Shockwave Medical (SWAV) lacks the necessary elements for a potential earnings surpass in its upcoming report. Be ready with the important projections.
Shockwave Medical (SWAV) ended the most recent trading session at $328.99, showing a slight increase of 0.04% from the day before.
Shockwave Medical (SWAV) closed the most recent trading session at $329, marking a slight increase of 0.45% from the previous day's closing price.
Shockwave Medical (SWAV) has a strong track record of surprising earnings and is well positioned for another successful quarterly report.
Shockwave Medical (SWAV) reveals the real-world findings of the REDUCER-I study, which aims to gather extended results on the Shockwave Reducer, an innovative therapy for refractory angina.
Shockwave Medical Inc (NASDAQ:SWAV) is in the spotlight today, after blue-chip pharmaceutical giant Johnson & Johnson (JNJ) announced it would buy the company for $12.5 billion, boosting its portfolio of cardiovascular disease treatment devices.
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
A report surfaced that Johnson & Johnson was in talks to acquire Shockwave, though neither company has confirmed the rumors. An analyst initiated coverage on the stock.
What type of business is ShockWave Medical?
ShockWave Medical, Inc. is a company that specializes in the development, manufacturing, and commercialization of products designed to treat cardiovascular diseases. Founded in 2009 and headquartered in Santa Clara, California. The company's flagship products are catheters and IVL systems for the treatment of ischemic heart disease, atherosclerotic cardiovascular diseases. The company sells its IVL systems to hospitals and also utilizes a network of distributors for sales outside the United States. The geography of direct sales includes markets in the United States, Germany, Austria, and Switzerland, with the distributor network covering over 35 countries.
What sector is ShockWave Medical in?
ShockWave Medical is in the Healthcare sector
What industry is ShockWave Medical in?
ShockWave Medical is in the Medical Devices industry
What country is ShockWave Medical from?
ShockWave Medical is headquartered in United States
When did ShockWave Medical go public?
ShockWave Medical initial public offering (IPO) was on 07 March 2019
What is ShockWave Medical website?
https://www.shockwavemedical.com
Is ShockWave Medical in the S&P 500?
No, ShockWave Medical is not included in the S&P 500 index
Is ShockWave Medical in the NASDAQ 100?
No, ShockWave Medical is not included in the NASDAQ 100 index
Is ShockWave Medical in the Dow Jones?
No, ShockWave Medical is not included in the Dow Jones index
When does ShockWave Medical report earnings?
The next expected earnings date for ShockWave Medical is 05 August 2024